Loading...
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma
BACKGROUND: The outcome of patients who progress on front-line immune-based combination regimens (IC) including immune checkpoint inhibitors (CPI) and receive subsequent systemic therapy is unknown. METHODS: Retrospective analysis of consecutive patients with clear-cell mRCC who progressed on one of...
Na minha lista:
| Udgivet i: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6048048/ https://ncbi.nlm.nih.gov/pubmed/29795307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0104-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|